Skip to main content
Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will be devoted to a single timely topic, with series of in-depth reviews, written by leaders in the field, covering a range of current topics on drug targets. These issues will be organized and led by a guest editor who is a recognized expert in the overall topic. As the discovery, identification, characterisation and validation of novel human drug targets for drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

More about this publication?
Volume 16, Number 2, 2015

Articles

Free Content Meet the Editorial Board:
pp. 93-93(1)
Author: S. Yepes, Manuel

Favourites:
ADD

Free Content Editorial (Mini-Thematic Issue: Morphological and Molecular Backgrounds for Personalized Therapies in Genitourinary Cancers)
pp. 94-95(2)
Authors: Montironi, Rodolfo; Scarpelli, Marina; Santoni, Matteo; Lopez-Beltran, Antonio; Cheng, Liang

Favourites:
ADD

Morphologic and Molecular Backgrounds for Personalized Management of Genito-Urinary Cancers: An Overview
pp. 96-102(7)
Authors: Montironi, Rodolfo; Santoni, Matteo; Lopez-Beltran, Antonio; Cheng, Liang; Moch, Holger; Scarpelli, Marina

Favourites:
ADD

Molecular Foundations for Personalized Therapy in Prostate Cancer
pp. 103-114(12)
Authors: W. Fisher, Kurt; Montironi, Rodolfo; Lopez Beltran, Antonio; Moch, Holger; Wang, Lisha; Scarpelli, Marina; R. Williamson, Sean; O. Koch, Michael; Cheng, Liang

Favourites:
ADD

Bladder Cancer: Molecular Determinants of Personalized Therapy
pp. 115-124(10)
Authors: Lopez-Beltran, Antonio; Santoni, Matteo; Massari, Francesco; Ciccarese, Chiara; Tortora, Giampaolo; Cheng, Liang; Moch, Holger; Scarpelli, Marina; Reymundo, Carlos; Montironi, Rodolfo

Favourites:
ADD

Oncotargets in Different Renal Cancer Subtypes
pp. 125-135(11)
Authors: Moch, Holger; Montironi, Rodolfo; Lopez-Beltran, Antonio; Cheng, Liang; Mischo, Axel

Favourites:
ADD

Drug Nanocrystals: Four Basic Prerequisites for Formulation Development and Scale-Up
pp. 136-147(12)
Authors: Mohana Raghava Srivalli, Kale; Mishra, Brahmeshwar

Favourites:
ADD
Favourites:
ADD

ATP Citrate Lyase (ACLY): A Promising Target for Cancer Prevention and Treatment
pp. 156-163(8)
Authors: Devi Khwairakpam, Amrita; Singh Shyamananda, Mayengbam; Lalduhsaki Sailo, Bethsebie; Raju Rathnakaram, Sivakumar; Padmavathi, Ganesan; Kotoky, Jibon; B. Kunnumakkara, Ajaikumar

Favourites:
ADD

Inhibition of the VEGF/VEGFR Pathway Improves Survival in Advanced Kidney Cancer: A Systematic Review and Meta-Analysis
pp. 164-170(7)
Authors: Iacovelli, Roberto; N. Sternberg, Cora; Porta, Camillo; Verzoni, Elena; de Braud, Filippo; Escudier, Bernard; Procopio, Giuseppe

Favourites:
ADD

Anti-IgE Therapy with Omalizumab for Severe Asthma: Current Concepts and Potential Developments
pp. 171-178(8)
Authors: Pelaia, Girolamo; Vatrella, Alessandro; Teresa Busceti, Maria; Gallelli, Luca; Terracciano, Rosa; Maselli, Rosario

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content